WCG
GILD icon

Weaver Consulting Group’s Gilead Sciences GILD Stock Holding History

Weaver Consulting Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$922K Buy
6,183
+106
+2% +$14.9K 0.18% 112
2026
Q2 		$768K Buy
+6,077
New +$801K 0.16% 120
2020
Q4 		– Sell
-1,120
Closed -$71K – 427
2020
Q3 		$71K Sell
1,120
-160
-13% -$11.1K 0.04% 221
2020
Q2 		$99K Buy
1,280
+55
+4% +$4.21K 0.06% 189
2020
Q1 		$92K Buy
1,225
+706
+136% +$48.8K 0.06% 169
2019
Q4 		$33K Hold
519
– – 0.02% 291
2019
Q3 		$35K Hold
519
– – 0.02% 265
2019
Q2 		$35K Hold
519
– – 0.02% 256
2019
Q1 		$34K Buy
+519
New +$34.5K 0.01% 570

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Weaver Consulting Group's GILD Position: Q3 2026 in Review

Weaver Consulting Group increased its Gilead Sciences (GILD) stake by 1.7% in Q3 2026, buying an estimated $14.9K and bringing the position to 6,183 shares worth $922K. The position accounts for 0.18% of the portfolio, ranked #112.

Weaver Consulting Group first reported a position in GILD in Q1 2019 and has held it in 9 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Weaver Consulting Group held 6,183 shares of Gilead Sciences worth $922K as of Q3 2026.
  • Weaver Consulting Group bought 106 Gilead Sciences shares in Q3 2026, an estimated $14.9K.
  • Gilead Sciences made up 0.18% of Weaver Consulting Group's portfolio in Q3 2026, its #112 holding.
  • Weaver Consulting Group first reported a position in Gilead Sciences in Q1 2019 and has held it in 9 quarters since.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Weaver Consulting Group's 13F filing for Q3 2026, filed 7 Oct 2026.